One of the most dreaded consequences of cancer is when the disease metastasizes — meaning it spreads from the primary site where it started to other parts of the body. But University of California, Riverside (UCR) scientists have announced what could be a major breakthrough in halting metastasis. They’ve discovered components in pomegranate juice that [...]
By Brian Wolak BRIGHTON, Mass. — Nano Terra has completed a $2.30 million equity offering, raising …
VICTORIA, Australia, April 26, 2011 /PRNewswire/ — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has gained certification of its Australian laboratory under the US Clinical Laboratories Improvements Amendments (CLIA) (42 U.S.C. section 263a) regulated by the Centers for Medicare and Medicaid (CMS). The certification was issued by the CMS central office which is responsible for [...]
A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration (AMD), according to a new in vivo study by researchers at Tufts University School of Medicine. Led by senior author Rajendra Kumar-Singh, PhD, the researchers demonstrated for the first time that CD59 delivered by [...]
A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration, according to a new in vivo study by researchers at Tufts University School of Medicine.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a new study.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease (CGD) in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology. CGD prevents neutrophils, a type [...]
April 29, 2011 — A gene therapy approach using a protein called CD59, or protection, shows promise in slowing the signs of age-related macular degeneration (AMD), according to a new study from Tufts University School of Medicine.
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology.
A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration (AMD), according to a new in vivo study by researchers at Tufts University School of Medicine. Led by senior author Rajendra Kumar-Singh, PhD, the researchers demonstrated for the first time that CD59 delivered by [...]
(Tufts University, Health Sciences) A study shows promise in slowing age-related macular degeneration (AMD). Tufts researchers demonstrate for the first time that a gene therapy approach to deliver CD59, an inhibitor of complement, can significantly reduce uncontrolled blood vessel growth and cell death that is typical in AMD, the most common cause of blindness in [...]
Authors: F J T Staal, C Baum, C Cowan, E Dzierzak, S Hacein-Bey-Abina, S Karlsson, T Lapidot, I Lemischka, S Mendez-Ferrer, H Mikkers, K Moore, E Moreno, C L Mummery, C Robin, T Suda, M Van Pel, G Vanden Brink, J J Zwaginga & W E Fibbe (Source: Leukemia)
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease (CGD) in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a study published in Blood, the Journal of the American Society of Hematology. CGD prevents neutrophils, a type [...]
Researchers have developed an effective technique that uses gene therapy on stem cells to correct chronic granulomatous disease in cell culture, which could eventually serve as a treatment for this rare, inherited immune disorder, according to a new study. (Source: ScienceDaily Headlines)
Authors: J A Broderick & P D Zamore (Source: Gene Therapy)
Authors: M Gonzalez-Aparicio, I Mauleon, P Alzuguren, M Bunuales, G Gonzalez-Aseguinolaza, C San Martín, J Prieto & R Hernandez-Alcoceba (Source: Gene Therapy)
Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα Gene Therapy advance online publication, April 28, 2011. doi:10.1038/gt.2011.72 Authors: I-K Choi, J-S Lee, S-N Zhang, J Park, C H Sonn, K-M Lee & C-O Yun (Source: Gene Therapy)
The understanding of the hierarchical organization of the human hematopoietic system is of major biologic and clinical significance. The validity of the conventional model in which hematopoiesis is solely maintained by a pool of multipotent long-term hematopoietic stem cells (LT-HSCs) has been recently challenged by several mouse studies. These new data point to the existence [...]
Fluorescent proteins enabled them to see ‘transcription’ in real time, study says Source: HealthDay Related MedlinePlus Page: Genes and Gene Therapy (Source: MedlinePlus Health News) MedWorm Sponsor Message: Find out how you can get your message posted here and on over 100,000 other medical web pages in just a couple of days, plus support MedWorm [...]
Tay-Sachs disease, a devastating congenital error in metabolism of central nervous system fats, is caused by a rare genetic mutation. (Source: Health Facts and Fears)
